Tag Archive | cardiology
LabBook March 8, 2013
Impulse control, diabetes evolution, focal therapy and more in this week’s LabBook.
LabBook June 22, 2012
Welcome to LabBook, our weekly roundup of University of Chicago Medicine & Biological Sciences research news from around campus and the world wide web. Each Friday, LabBook will recap the week on the blog, link to news stories about our faculty and studies, and briefly summarize a handful of recent publications by our researchers. THIS […]
AHA + CFD + NATO = STEMI
“Time is muscle,” cardiologists say. When someone has a heart attack, they don’t have much time. The longer blood flow through a coronary artery is blocked, the more heart muscle dies, and delays can mean permanent heart damage or death. Patients having a severe heart attack need to get to a hospital, the right hospital, […]
A Healthy Sex Life After a Heart Attack
by Tiffani Washington Whether it’s from a movie, celebrity hearsay or some other largely fictional account, most of us can recall a tale of someone experiencing a heart attack in the throes of passion. In reality, only about 1 percent of all heart attacks occur during sex, and far less than 1 percent of heart […]
Mitochondria and Cancer: The Trigger Becomes the Treatment
Once considered the cause of cancer, a tiny organelle known as the “powerhouse of the cell” may soon spawn a new treatment. In 1955, Otto Warburg, recipient of the 1931 Nobel Prize for Medicine or Physiology, attributed cancer to damage to the mitochondria, tiny structures within each cell that are involved in energy production, the […]
A Tiny Turntable and a Nano-Portal
When scientists picture the miniature machines that live inside cells, they often have to settle for indirect evidence and a bit of imagination. Proteins on the nanoscale – one million times smaller than a millimeter – can’t be seen with your typical microscope, so scientists turn to electrical measurements, genetic mutations, and chemical assays to […]
Building Better Drugs, in Five Steps or Less
When the drug ezetimibe was approved in 2002, it was hailed by its makers as a new tool for lowering cholesterol and fighting heart disease in patients. In clinical trials, the drug (marketed by Merck as Zetia) lowered levels of low-density lipoprotein or LDL, the so-called “bad cholesterol” associated with atherosclerosis, the thickening of blood […]
Linkage 7/29: Debt & Doctors, New Hearts, and Brain Models
One of the sectors closely monitoring the debt debate in Washington is the medical world, where hospitals, physicians, and patients anxiously await the final agreement on cuts to Medicare and Medicaid. Of particular concern to academic medical centers [pdf] are proposed cuts to graduate medical education, funding used to pay the salary of residents and […]
Genes Versus The Environment Inside
The odds of acquiring a disease are often portrayed as a tug of war between two foes: genes and environment. The battle is not always evenly matched. A disease such as cystic fibrosis is entirely genetic – if a child inherits the mutated CFTR gene from both parents, no environment will prevent the condition. On […]
